This protocol is judged by an institutional evaluate board, an independent group that evaluations any medical trials involving individuals. If a review consists of a Schedule I drug, once the board approves the protocol as moral, the researchers really need to apply for an investigational new drug (IND) variety in the FDA. While copyright therap